西洛他唑 - CAS:73963-72-1 - 研锐化学-溶剂、试剂、原料、耗材、仪器、[研化商城]

西洛他唑

英文名： Cilostazol 别名：西洛他唑;6-[4-(1-环己基-1H-戊四唑-5-基)丁氧基]-3,4-二氢-2(1H)-喹诺酮;西斯他唑;四氮唑(西洛他唑中间体);6-[4-(1-环己基-1H-四唑-5-基)丁氧基]-3,4-二氢-2(1H)-喹诺酮;2,3-二氯吡嗪;6-[4-(1-环己基-1H-四氮唑-5-基)丁基]3,4-二氢喹啉-2-(1H)-酮;Cilostazol 西洛他唑;西洛他唑 Cilostazol;西洛他唑 USP标准品;西洛他唑标准品(JP);6-[4-(1-环己基-1H-四唑-5-基)丁氧基]-3,4-二氢-2(1H)-喹啉酮;雷公藤红素;雷公藤红素,南蛇藤素,苦瓜苷;西洛他唑(对照品)

商品编号：R021984-250mg 规格：250mg 纯度：98%

CAS号： 73963-72-1 分子式：C20H27N5O2 分子量：369.46

价格	¥ 205.00 （请登录会员查看折扣价）
货期	5~7个工作日

数量

中文名称：	西洛他唑
中文别名：	西洛他唑;6-[4-(1-环己基-1H-戊四唑-5-基)丁氧基]-3,4-二氢-2(1H)-喹诺酮;西斯他唑;四氮唑(西洛他唑中间体);6-[4-(1-环己基-1H-四唑-5-基)丁氧基]-3,4-二氢-2(1H)-喹诺酮;2,3-二氯吡嗪;6-[4-(1-环己基-1H-四氮唑-5-基)丁基]3,4-二氢喹啉-2-(1H)-酮;Cilostazol 西洛他唑;西洛他唑 Cilostazol;西洛他唑 USP标准品;西洛他唑标准品(JP);6-[4-(1-环己基-1H-四唑-5-基)丁氧基]-3,4-二氢-2(1H)-喹啉酮;雷公藤红素;雷公藤红素,南蛇藤素,苦瓜苷;西洛他唑(对照品)
smiles：	O=C1NC2=C(C=C(OCCCCC3=NN=NN3C4CCCCC4)C=C2)CC1
英文名称：	Cilostazol
英文别名：	Cilostazol;CILOSTAZOL INTERMEDIATES;6-[4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL)BUTOXY]-3,4-DIHYDRO-2(1H)-QUINOLINONE;6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1h)-quinolinone additional name: 6-[4-(1-cyclohexyl-5-tetrazolyl)butoxy]-1,2,3,4- tetrahydro-2-oxoquinolinone;CILASTAZOL;CILOSTAZOLE;RETAL;OPC 13013;OPC 21;6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one;Cilostal;CILOSTAZOL JP;PLETAAL;PLETAL;6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone;Pletaal;6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone;6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone Additional name: 6-[4-(1-Cyclohexyl-5-tetrazolyl)butoxy]-1,2,3,4- tetrahydro-2-oxoquinolinone;SR-01000003107;D01896;SR-01000003107-4;F20538;NCGC00022153-02;6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one;6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one;Opera_ID_488;Lopac0_000218;AB00382988_16;AB00382988_15;HMS3260L17;N7Z035406B;NCGC00015207-04;BCPP000279;AB00382988-14;SCHEMBL16128;CILOSTAZOL [MI];SMR000058428;SW199053-2;NCGC00022153-04;HMS3268O09;EU-0100218;C 0737;2(1H)-Quionlinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-;Cilostazol, >=98% (HPLC), powder;Tocris-1692;GTPL7148;Tox21_110098;6-[4-(l-cyclohexyl-1,2,3,4-tetrazol-5-yl)butoxyl]-3,4-dihydrocarbostyril;HMS3713F16;AC-4334;6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one;DTXSID9045132;OPC 13013; OPC 21; Pletaal;Tox21_110098_1;Q258591;6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone;Cilostazolum (INN-Latin);BRD-K67017579-001-13-3;NCGC00015207-03;HMS2234C06;3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone;MLS000758281;CILOSTAZOL [WHO-DD];OPC-13013;NCGC00015207-25;CS-1759;CILOSTAZOL [VANDF];SDCCGSBI-0050206.P003;C2587;Pharmakon1600-01505230;Cilostazolum (Latin);DTXCID7025132;CILOSTAZOL [MART.];OPC-21;Cilostazol, United States Pharmacopeia (USP) Reference Standard;2(1H)-Quinolinone, 3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-;Tox21_500218;BCP0726000145;BRD-K67017579-001-04-2;NCGC00022153-07;73963-72-1;HSDB 8312;MLS001076067;Z1501485368;HMS3412B18;NCGC00015207-05;NCGC00015207-08;CILOSTAZOL [USP MONOGRAPH];CCG-39646;NCGC00022153-06;Cilastatin sodium, Antibiotic for Culture Media Use Only;CHEMBL799;Cilostazolum [INN-Latin];BRD-K67017579-001-07-5;HMS1922N15;BRN 3632107;6-(4-(1-CYCLOHEXYL-1H-TETRAZOL-5-YL)BUTOXY)QUINOLINE-2,3(1H,4H)-DIONE;MLS000028470;CHEBI:31401;NCGC00015207-09;KBio3_002259;6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy)-3,4-dihydro-1H-quinolin-2-one;NCGC00015207-07;SR-01000003107-2;6-[4-(1-cyclohexyl-1H-1,2,3,4-tetrazol-5-yl)butoxy]-1,2,3,4-tetrahydroquinolin-2-one;Spectrum4_000772;HMS2096F16;NCGC00015207-01;FT-0645036;BSPBio_002759;NSC758936;HMS3676B18;2(1H)-Quin...
CAS号：	73963-72-1
分子式：	C20H27N5O2
分子量：	369.46
密度：
熔点：
沸点：
闪点：
水溶性：
蒸气压：

搜索质检报告(COA)

搜索MSDS